Asstrodyne TDI

company

About

Spherics engages in developing and manufacturing oral pharmaceutical products.

  • 501 - 1000

Details

Last Funding Type
Series C
Last Funding Money Raised
$26.40M
Industries
Biopharma,Biotechnology,Manufacturing,Pharmaceutical
Founded date
Jan 1, 1997
Number Of Employee
501 - 1000
Operating Status
Active

As of August 4, 2008, Spherics, Inc. went out of business. Spherics, Inc., a pharmaceutical company, engages in developing and manufacturing oral pharmaceutical products for central nervous system conditions, gastrointestinal disorders, and cancer. It develops oral systems based on the application of bioadhesive polymers to oral dosage forms. The company also provides products for neurological disorders, such as Alzheimer's, Parkinson's, and multiple sclerosis, as well as for stroke, epilepsy, chronic pain, and migraine. The company was founded in 1997 and is headquartered in Mansfield, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$36.40M
Asstrodyne TDI has raised a total of $36.40M in funding over 2 rounds. Their latest funding was raised on May 13, 2005 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 13, 2005 Series C $26.40M 1 Advent International Detail
Aug 16, 2002 Series B $10M 2 Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Asstrodyne TDI is funded by 3 investors. Advent International and POD Holding are the most recent investors.
Investor Name Lead Investor Funding Round
Advent International Yes Series C
POD Holding Series B
Eastman Ventures Series B